A novel estimand to adjust for rescue treatment in randomized clinical trials-Reference-Cited by-同舟云学术

A novel estimand to adjust for rescue treatment in randomized clinical trials

Published:2021-02-10 Issue:9 Volume:40 Page:2257-2271
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statistics in Medicine

Author:

Michiels Hege¹^ORCID,Sotto Cristina²,Vandebosch An²,Vansteelandt Stijn¹³^ORCID

Affiliation:

1. Department of Applied Mathematics, Computer Science and Statistics Ghent University Ghent Belgium

2. Janssen R&D Janssen Pharmaceutica NV Beerse Belgium

3. Department of Medical Statistics London School of Hygiene and Tropical Medicine London UK

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.8901

Reference30 articles.

1. International Council for Harmonisation. Addendum on estimands and sensitivity analysis in clinical trials; 2019.https://database.ich.org/sites/default/files/E9‐R1_Step4_Guideline_2019_1203.pdf.

2. Randomized clinical trials with added rescue medication: some approaches to their analysis and interpretation

3. Estimands and the patient journey: addressing the right question in oncology clinical trials;Degtyarev E;JCO Precis Oncol,2019

4. Identifiability and Exchangeability for Direct and Indirect Effects

5. Estimating causal effects of treatments in randomized and nonrandomized studies.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Causal Mediation Approach to Account for Interaction of Treatment and Intercurrent Events: Using Hypothetical Strategy;Statistics in Medicine;2024-09-05

2. Current developments of the estimand concept;Pharmaceutical Statistics;2024-04-27

3. Adjusting for Time-Varying Treatment Switches in Randomized Clinical Trials: The Danger of Extrapolation and How to Address It;Statistics in Biopharmaceutical Research;2023-11-29

4. GRADE concept 4: rating the certainty of evidence when study interventions or comparators differ from PICO targets;Journal of Clinical Epidemiology;2023-07

5. Comment on” Estimands and their Estimators for Clinical Trials Impacted by the COVID-19 Pandemic: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions”;Statistics in Biopharmaceutical Research;2023-01-02